| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 12,000 | $70.05 | $840,596.30 | -2.2% | +38.9% | +150.5% | |
| Feb 6, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 34,029 | $70.03 | $2,383,129.14 | -32.5% | +38.4% | +152.1% | |
| Feb 6, 2024 | DHR Danaher Corp /de/ | List Teri55 | Director | Sell | 3,289 | $248.32 | $816,724.48 | -14.3% | -0.3% | -14.5% | |
| Feb 6, 2024 | XGN Exagen Inc. | Adawi Kamal | CFO And Corporate Secretary | Sell | 6,738 | $1.95 | $13,133.04 | -3.6% | -31.3% | +165.2% | |
| Feb 6, 2024 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 21,249 | $23.24 | $493,818.41 | -5.0% | +1.8% | +17.2% | |
| Feb 5, 2024 | RVTY Revvity, Inc. | Singh Prahlad R.53 | Please See Remarks | Sell | 21,217 | $104.28 | $2,212,479.85 | -9.9% | -1.0% | +18.5% | |
| Feb 5, 2024 | RVTY Revvity, Inc. | Goldberg Joel S58 | Please See Remarks | Sell | 15,475 | $104.28 | $1,613,696.50 | -11.6% | -1.0% | +18.5% | |
| Feb 1, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 22,281 | $67.73 | $1,509,080.99 | -24.0% | +38.1% | +159.5% | |
| Jan 29, 2024 | OPK Opko Health, Inc. | Krasno Richard M | Director | Buy | 30,000 | $0.99 | $29,838.00 | +40.9% | +21.6% | +47.1% | |
| Jan 29, 2024 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 716 | $1.37 | $980.92 | -0.4% | -11.1% | +255.6% | |
| Jan 29, 2024 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 526 | $1.37 | $720.62 | -0.4% | -11.1% | +255.6% | |
| Jan 29, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 3,426 | $65.09 | $223,002.11 | -1.7% | +41.6% | +153.1% | |
| Jan 29, 2024 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 2,358 | $65.09 | $153,484.81 | -2.1% | +41.6% | +153.1% | |
| Jan 29, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 546 | $65.09 | $35,539.74 | -0.1% | +41.6% | +153.1% | |
| Jan 29, 2024 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 4,265 | $65.09 | $277,613.54 | -2.0% | +41.6% | +153.1% | |
| Jan 29, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 3,235 | $65.09 | $210,569.71 | -3.4% | +41.6% | +153.1% | |
| Jan 29, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 14,813 | $65.09 | $964,194.46 | -5.7% | +41.6% | +153.1% | |
| Jan 26, 2024 | AWHL Aspira Women's Health Inc. | Schuler Jack W45 | - | Buy | 28,500 | $0.00 | - | +1.5% | - | - | |
| Jan 26, 2024 | AWHL Aspira Women's Health Inc. | Sandford Nicole | President &CEO | Buy | 2,400 | $0.00 | - | +4.1% | - | - | |
| Jan 24, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 944 | $67.00 | $63,248.00 | -1.4% | +38.8% | +161.9% | |
| Jan 23, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,973 | $66.45 | $197,565.07 | -1.5% | +33.2% | +158.5% | |
| Jan 22, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 351 | $68.16 | $23,924.16 | - | +32.9% | +151.1% | |
| Jan 22, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 1,958 | $68.16 | $133,457.28 | -1.1% | +32.9% | +151.1% | |
| Jan 22, 2024 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 892 | $68.16 | $60,798.72 | -0.5% | +32.9% | +151.1% | |
| Jan 22, 2024 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 193 | $3.24 | $625.32 | -0.8% | +210.1% | +2119.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.